Results 191 to 200 of about 237,743 (361)

Autoantibodies in early breast cancer: a stage-related phenomenon? [PDF]

, 1978
A R Turnbull, Debi Turner, James D. Fraser, R. Stephen Lloyd, Cs. Láng, Ralph Wright   +5 more
openalex   +1 more source

RNA Binding Protein YTHDF2 Inhibits Synovial Fibroblast Inflammation and Bone Injury in Rheumatoid Arthritis by Reducing the mRNA Stability of IL‐6R

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study examined YTHDF2's role in modulating IL‐6R signaling to regulate synovial fibroblast inflammation and bone damage in rheumatoid arthritis (RA). Synovial tissues of RA patients were collected. Human fibroblast‐like synoviocyte (FLS), MH7A cell line, was induced with TNF‐α and transfected. Cell proliferation was assessed using MTT and
Yan Zhang, Xu‐Qing Cao, Xiao‐Li Ma, Yin‐Yan Guo, Tao Zhang, Li‐Li Wu, Ya‐Shan Yang, Chun‐Fang Hao, Wei‐Li Liu, Jiang‐Tao Guo   +9 more
wiley   +1 more source

Evaluating IL1RA-Autoantibodies Across SARS-CoV-2-Related Diseases. [PDF]

Scand J Immunol
Behere A, Hallberg P, Cederholm A, Cavalli M, Yalcinkaya A, COVID‐HGE, Bastard P, Puel A, Casanova JL, Wadelius M, Brodin P, Landegren N.   +11 more
europepmc   +1 more source

Low Incidence of Rheumatoid Factor and Autoantibodies in Nigerian Patients with Rheumatoid Arthritis [PDF]

, 1970
Brian Greenwood, E M Herrick
openalex   +1 more source

Identification of autoantibodies against HIF1a in patients with anorexia nervosa and their potential role in hepatic cytolysis. [PDF]

Sci Rep
Joshkon A, Reytier C, Bertin D, Castets S, Reynaud R, Bat F, Mege JL, Blot-Chabaud M, Darmon P, Bardin N.   +9 more
europepmc   +1 more source

Development of Complement-Fixing 19S, Anti-Heart Mitochondria Autoantibody, Following Myocardial Infarction in Dogs [PDF]

, 1971
R. Neal. Pinckard, Merle S. Olson, Robert A. O’Rourke, John D. Palmer, Robert E. Kelley, Samuel Goldfein   +5 more
openalex   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Thymic Microenvironment Remodeling in Cancer Cachexia as a Determinant of Checkpoint Inhibitor Efficacy and Toxicity. [PDF]

J Cachexia Sarcopenia Muscle
Huang RK, Xing YF, Wu XY, Shi ZH, Wei L, Lv XT, Peng LJ, Pang XQ, Yang QT, Li X.   +9 more
europepmc   +1 more source

Autoantibodies to Tamm-Horsfall protein in detection of vesicoureteric reflux and kidney scarring. [PDF]

, 1977
Anders Fasth, L Å Hanson, A. W. Asscher
openalex   +1 more source

Immune Characterization of a Vietnamese Cohort With Idiopathic Inflammatory Myopathies

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Idiopathic inflammatory myopathies (IIMs) are classified into five subtypes that are associated with distinct groups of myositis‐specific antibodies (MSAs). Variations in the prevalence, genetic predisposition and clinical manifestations exist in patients with IIM from different ethnic backgrounds.
Yue‐Bei Luo, Maho Nakazawa, Nham Pham Thi Minh, Léo Heinon, Inger Nennesmo, Johan Rönnelid, Ingrid E. Lundberg, Thuy Nguyen Thi Phuong, Begum Horuluoglu   +8 more
wiley   +1 more source